Canada Pension Plan Investment Board increased its stake in shares of Hill-Rom Holdings Inc (NYSE:HRC) by 42.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,700 shares of the medical technology company’s stock after buying an additional 5,000 shares during the period. Canada Pension Plan Investment Board’s holdings in Hill-Rom Holdings were worth $1,329,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of HRC. Vanguard Group Inc. boosted its position in Hill-Rom Holdings by 17.5% in the first quarter. Vanguard Group Inc. now owns 5,737,481 shares of the medical technology company’s stock valued at $405,066,000 after buying an additional 853,385 shares during the last quarter. BlackRock Inc. boosted its position in Hill-Rom Holdings by 13,535.4% in the first quarter. BlackRock Inc. now owns 5,067,064 shares of the medical technology company’s stock valued at $357,736,000 after buying an additional 5,029,903 shares during the last quarter. State Street Corp boosted its position in Hill-Rom Holdings by 3.4% in the first quarter. State Street Corp now owns 1,637,462 shares of the medical technology company’s stock valued at $115,603,000 after buying an additional 53,082 shares during the last quarter. Neuberger Berman Group LLC boosted its position in Hill-Rom Holdings by 15.6% in the first quarter. Neuberger Berman Group LLC now owns 1,480,242 shares of the medical technology company’s stock valued at $104,505,000 after buying an additional 199,901 shares during the last quarter. Finally, Bank of Montreal Can boosted its position in Hill-Rom Holdings by 2.1% in the second quarter. Bank of Montreal Can now owns 1,007,525 shares of the medical technology company’s stock valued at $80,206,000 after buying an additional 20,495 shares during the last quarter. 82.31% of the stock is owned by institutional investors.

Hill-Rom Holdings Inc (NYSE HRC) opened at 74.54 on Tuesday. The firm has a 50 day moving average of $77.92 and a 200-day moving average of $73.80. Hill-Rom Holdings Inc has a 52 week low of $50.50 and a 52 week high of $84.65. The stock has a market capitalization of $4.91 billion, a PE ratio of 43.44 and a beta of 1.22.

Hill-Rom Holdings (NYSE:HRC) last announced its earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.01. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The company had revenue of $689.10 million for the quarter, compared to analyst estimates of $695.50 million. During the same period in the prior year, the company posted $0.81 EPS. Hill-Rom Holdings’s quarterly revenue was up 5.1% on a year-over-year basis. On average, equities analysts predict that Hill-Rom Holdings Inc will post $3.82 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date is Thursday, September 14th. Hill-Rom Holdings’s payout ratio is 41.62%.

COPYRIGHT VIOLATION NOTICE: “Hill-Rom Holdings Inc (HRC) Shares Bought by Canada Pension Plan Investment Board” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/29/hill-rom-holdings-inc-hrc-shares-bought-by-canada-pension-plan-investment-board.html.

HRC has been the subject of several research analyst reports. Stifel Nicolaus raised their target price on shares of Hill-Rom Holdings from $70.00 to $84.00 and gave the company a “buy” rating in a research note on Monday, May 1st. Needham & Company LLC initiated coverage on shares of Hill-Rom Holdings in a research note on Thursday, June 29th. They set a “buy” rating and a $95.00 target price for the company. Zacks Investment Research raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $87.00 target price for the company in a research note on Friday, June 2nd. Barclays PLC raised their target price on shares of Hill-Rom Holdings from $80.00 to $86.00 and gave the company an “overweight” rating in a research note on Friday, June 9th. Finally, ValuEngine raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company. Hill-Rom Holdings has a consensus rating of “Buy” and a consensus price target of $88.17.

In other Hill-Rom Holdings news, SVP Andreas G. Frank sold 10,660 shares of the company’s stock in a transaction that occurred on Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total value of $838,089.20. Following the transaction, the senior vice president now directly owns 28,988 shares of the company’s stock, valued at approximately $2,279,036.56. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 2.20% of the company’s stock.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Stock Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related stocks with our FREE daily email newsletter.